4/A: Purebase CFO Gains 400K Stock Options in Equity Grants

Purebase Corp's Chief Financial Officer, Stephen Craig Gillings, reported the acquisition of 400,000 stock options through two separate grants.

Summary

• Stephen Craig Gillings, Chief Financial Officer of Purebase Corp (PUBC), reported changes in his beneficial ownership of company securities.
• On December 13, 2023, Mr. Gillings acquired 200,000 stock options to purchase Common Stock at an exercise price of $0.06 per share. These options become exercisable on December 11, 2024, and are set to expire on February 6, 2030.
• An additional 200,000 stock options were acquired on February 6, 2025, also with an exercise price of $0.06 per share. These options will become exercisable on February 6, 2026, and expire on February 6, 2031.
• These transactions were executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
• Following these reported transactions, Mr. Gillings beneficially owns a total of 400,000 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The acquisition of stock options by a key executive, especially under a Rule 10b5-1 plan, generally signals management's confidence in the company's future prospects and aligns their interests with long-term shareholder value creation. The low exercise price of $0.06 per share suggests significant potential upside if the company's stock performs well.

Positives

• The acquisition of stock options by the Chief Financial Officer demonstrates increased alignment of management's interests with those of shareholders.
• The options were granted at a low exercise price of $0.06 per share, suggesting potential for significant upside if the company's stock price appreciates.

Negatives

• The granting of stock options does not provide immediate cash flow to the company.
• Future exercise of these options could lead to dilution for existing shareholders.

Risks

• The value of the stock options is contingent on Purebase Corp's stock price rising above the $0.06 exercise price.
• Potential future dilution from the exercise of these options could negatively impact the per-share value for current shareholders.

Future Outlook

This filing primarily details insider equity transactions and does not contain forward-looking statements regarding the company's financial performance or strategic guidance, beyond the exercisability and expiration dates of the options themselves.

Industry Context

Stock option grants are a standard component of executive compensation packages across various industries, particularly in growth-oriented companies, designed to incentivize management to enhance long-term shareholder value. The use of a Rule 10b5-1 plan indicates a pre-arranged, non-discretionary transaction, which is a common practice for insiders to manage their equity holdings while adhering to insider trading regulations.

Comparison to Industry Standards

• Granting stock options to key executives like the CFO is a widely accepted practice in corporate compensation, aligning executive incentives with company performance and shareholder returns.
• The exercise price of $0.06 per share is relatively low, which is common for early-stage or smaller companies, or as a long-term incentive, aiming to provide significant upside potential if the company's valuation increases substantially.
• The use of a Rule 10b5-1 plan for these transactions is a standard corporate governance practice, demonstrating a commitment to transparent and pre-planned insider trading, reducing concerns about opportunistic trading.

Stakeholder Impact

• Shareholders: Potential for increased alignment of management interests with long-term shareholder value; potential for future share dilution upon option exercise.
• Management: Increased equity stake provides a direct financial incentive tied to the company's stock performance.

Next Steps

• The first grant of 200,000 stock options will become exercisable on December 11, 2024.
• The second grant of 200,000 stock options will become exercisable on February 6, 2026.
• The options will expire on their respective dates if not exercised.

Key Dates

Recommendation

The acquisition of stock options by the CFO, particularly under a 10b5-1 plan, is a positive signal indicating management confidence and alignment with shareholder interests. However, this filing is purely an insider transaction report and does not provide sufficient comprehensive financial or operational data to warrant a stronger recommendation. Investors should consider this positive signal in conjunction with the company's broader financial performance, strategic initiatives, and market conditions before making investment decisions.

Keywords

Purebase Corp, PUBC, Stephen Craig Gillings, CFO, Stock Options, Insider Trading, Form 4, Beneficial Ownership, Equity Compensation, Rule 10b5-1